CONTENTS:
- United States public health officials need to correct e-cigarette health misinformation [Editorial]. Pesko M.F., Cummings K.M., Douglas C.E., Foulds J., Miller T., Rigotti N.A., et al., p. 785-788.
- Use of Swedish smokeless tobacco during pregnancy: A systematic review of pregnancy and early life health risk. Brinchmann B.C., Vist G.E., Becher R., Grimsrud T.K., Elvsaas I., Underland V., et al., p. 789-803.
- The association between maternal and paternal substance use and child substance use, internalizing and externalizing problems: a systematic review and meta-analysis. McGovern R., Bogowicz P., Meader N., Kaner E., Alderson H., Craig D., et al., p. 804-818.
- Effectiveness of subnational implementation of minimum unit price for alcohol: policy appraisal modelling for local authorities in England. Brennan A., Angus C., Pryce R., Buykx P., Henney M., Gillespie D., et al., p. 819-833.
- Commentary on Brennan et al.: Pros and cons of minimum unit price for alcohol. Jiang H., Room R., p. 834-835.
- The association of lowered alcohol prices with birth outcomes and abortions: A population-based natural experiment. Luukkonen J., Junna L., Remes H., Martikainen P., p. 836-844.
- Commentary on Luukkonen et al.: Policy possibilities for reducing public health harms related to pregnant people's alcohol consumption. Roberts S.C.M., p. 845-846.
- Safety in solitude? Competing risks and drivers of solitary drug use among women who inject drugs and implications for overdose detection. Rosen J.G., Glick J.L., Zhang L., Cooper L., Olatunde P.F., Pelaez D., et al., p. 847-854.
- Commentary on Rosen et al.: Attending to the unique needs of pregnant and parenting women at risk for overdose. Wagner K.D., Lee L., p. 855-856.
- COVID-19 complications among patients with opioid use disorder: a retrospective cohort study across five major NYC hospital systems. Krawczyk N., Rivera B.D., Basaraba C., Corbeil T., Allen B., Schultebraucks K., et al., p. 857-869.
- Effect of a Veterans Health Administration mandate to case review patients with opioid prescriptions on mortality among patients with opioid use disorder: a secondary analysis of the STORM randomized control trial. Auty S.G., Barr K.D., Frakt A.B., Garrido M.M., Strombotne K.L., p. 870-879.
- Social genetic effects for drug use disorder among spouses. Salvatore J.E., Larsson Lönn S., Sundquist J., Kendler K.S., Sundquist K., p. 880-889.
- Long-term recovery from opioid use disorder: recovery subgroups, transition states and their association with substance use, treatment and quality of life. Craft W.H., Shin H., Tegge A.N., Keith D.R., Athamneh L.N., Stein J.S., et al., p. 890-900.
- Incidence of primary hepatitis C virus infection among people who inject drugs in Australia pre- and post-unrestricted availability of direct acting antiviral therapies. Iversen J., Wand H., McManus H., Dore G.J., Maher L., p. 901-911.
- Commentary on Iversen et al.: Adapting public health surveillance and monitoring to reflect how DAAs are changing the epidemiology of hepatitis C virus infection. Jordan A.E., p. 912-913.
- Effects of emotional arousal on the neural impact and behavioral efficacy of cigarette graphic warning labels. Shi Z., Wang A.L., Fairchild V.P., Aronowitz C.A., Padley J.H., Lynch K.G., et al., p. 914-924.
- Socio-economic status moderates within-person associations of risk factors and smoking lapse in daily life. Potter L.N., Schlechter C.R., Nahum-Shani I., Lam C.Y., Cinciripini P.M., Wetter D.W., p. 925-934.
- Cognitive training and remediation interventions for substance use disorders: a Delphi consensus study. Verdejo-Garcia A., Rezapour T., Giddens E., Khojasteh Zonoozi A., Rafei P., Berry J., et al., p. 935-951.
- Commentary on Verdejo-Garcia et al.: Cognitive training and remediation: identifying priorities for intervention research. Quilty L.C., p. 952-953.
- Development and evaluation of a risk algorithm predicting alcohol dependence after early onset of regular alcohol use. Bharat C., Glantz M.D., Aguilar-Gaxiola S., Alonso J., Bruffaerts R., Bunting B., et al., p. 954-966.
- Understanding successful policy innovation: The case of Portuguese drug policy. Moury C., Escada M., p. 967-978.
- Increase in cannabis-related emergency department presentations in the period immediately before legalization requires explanation. Smyth B.P., McCarron P., p. 979-980.
- Response to Smyth & McCarron: Increases in cannabis-attributable emergency department visits during different phases of the pre- and post-legalization period are multi-factorial. Myran D.T., Pugliese M., Tanuseputro P., Taljaard M., p. 980-982.